Finance

Lists
CHRS:NASDAQ
Coherus Oncology Inc
1,02 $
-1,22%
(-0,013) 1D
13 հոկ, 12:47:14 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CHRS...
Open
1,06 $
High
1,06 $
Low
1,00 $
Mkt. cap
157,19 մլն
Avg. vol.
1,40 մլն
Volume
551,34 հզր
52-wk high
2,62 $
52-wk low
0,97 $
EPS
-1,03 $
Beta
0,98
Shares outstanding
154,50 մլն
No. of employees
144
Open
1,06 $
High
1,06 $
Low
1,00 $
Mkt. cap
157,19 մլն
Avg. vol.
1,40 մլն
Volume
551,34 հզր
52-wk high
2,62 $
52-wk low
0,97 $
EPS
-1,03 $
Beta
0,98
Shares outstanding
154,50 մլն
No. of employees
144
News stories
From web sources and news partners
About Coherus Oncology Inc
CEODennis Lanfear
Employees144
Founded2010
HeadquartersՌեդվուդ Սիթի, Կալիֆոռնիա, Միացյալ Նահանգներ
Sector-
Analyst ratings
Based on 4 analysts giving stock ratings to CHRS in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for CHRS in the last 3 months.
Highest
Current 1,02 $
10,00 $ (+882,90%)
Average
7,75 $ (+661,75%)
Lowest
4,00 $ (+293,16%)
Analyst
Recommendation
Action
Price target
Projected
Date
Douglas Tsao
H.C. Wainwright
Buy
Reiterated
7,00 $
+588%
09/21/2026
Jason McCarthy
Maxim Group
Buy
Maintained
4,00 $
+293,2%
08/06/2026
Paul Jeng
Guggenheim
Buy
Maintained
10,00 $
+882,9%
08/06/2026
Jay Olson
Oppenheimer
Buy
Maintained
10,00 $
+882,9%
08/06/2026
Michael Nedelcovych
TD Cowen
Buy
Maintained
-
-
05/28/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
11,57 մլն
12,75 մլն
12,31 մլն
14,31 մլն
Cost of goods sold
3,72 մլն
4,04 մլն
3,81 մլն
4,24 մլն
Cost of revenue
3,72 մլն
4,04 մլն
3,81 մլն
4,24 մլն
Research and development expenses
27,25 մլն
30,97 մլն
21,54 մլն
21,45 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
22,83 մլն
21,01 մլն
23,10 մլն
20,95 մլն
Operating expense
50,08 մլն
51,98 մլն
44,65 մլն
42,40 մլն
Total operating expenses
53,80 մլն
56,03 մլն
48,46 մլն
46,64 մլն
Operating income
-42,23 մլն
-43,28 մլն
-36,15 մլն
-32,33 մլն
Other non operating income
2,14 մլն
-5,22 մլն
1,40 մլն
1,31 մլն
EBT including unusual items
-44,52 մլն
-46,35 մլն
-36,94 մլն
-33,35 մլն
EBT excluding unusual items
-42,42 մլն
-43,75 մլն
-36,94 մլն
-33,35 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-35,53 մլն
-37,64 մլն
-38,33 մլն
-20,63 մլն
Net profit margin
-307,07%
-295,29%
-311,35%
-144,20%
Earnings per share
-0,33
-0,34
-0,25
-0,19
Interest and investment income
-
7,00 մլն
-
-
Interest expense
-2,32 մլն
-2,25 մլն
-2,19 մլն
-2,32 մլն
Net interest expenses
-2,32 մլն
4,75 մլն
-2,19 մլն
-2,32 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-41,27 մլն
-42,38 մլն
-35,27 մլն
-31,47 մլն
Gain or loss from assets sale
-
-338,32 մլն
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google Apps